124icg250
Showing 1 - 1 of 1
Renal Cancer Trial in New York (124IcG250)
Active, not recruiting
- Renal Cancer
- 124IcG250
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 4, 2022